A Day Up For Matinas BioPharma Holdings, Inc.
Fri, Aug 15, 2025 at 07:55 PM
Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT) shot up at $2.36, representing a gain of 43%. On Fri, Aug 15, 2025, MTNB:NYSEMKT touched a New 2-Week High of $2.36. The stock appeared on our News Catalysts scanner on Sat, Aug 09, 2025 at 03:22 AM in the 'INVESTOR UPDATE' category. From Fri, Aug 01, 2025, the stock recorded 60.00% Up Days and 72.73% Green Days
The stock spiked on Fri, Aug 15, 2025 at $3.09 with a volume of 22M+.
About Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT)
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company engaged in identifying & developing safe and effective broad spectrum therapeutics for the treatment of serious and life-threatening infections.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 138.1%
- Perfect Moment Ltd. Common Stock (PMNT:NYSEMKT), 91.56%
- SRx Health Solutions Inc. (SRXH:NYSEMKT), 84.64%
- IO Biotech, Inc. (IOBT:NASDAQ), 68.75%
- Precigen, Inc. (PGEN:NASDAQ), 58.92%
- Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 43.03%
- Pioneer Power Solutions, Inc. (PPSI:NASDAQ), 39.87%
- Sunrun Inc. (RUN:NASDAQ), 32.82%
- Fossil Group, Inc. (FOSL:NASDAQ), 31.91%
- flyExclusive, Inc. (FLYX:NYSEMKT), 28.31%